FDA Approves Dupixent® (dupilumab) as First Treatment…
TARRYTOWN, N.Y. and PARIS, May 20, 2022 -Dupixent is the first and only medicine indicated to treat…
Tag: Eosinophilic Esophagitis
Late-breaking Data at 2022 AAAAI Annual Meeting Show…
TARRYTOWN, N.Y. and PARIS, Feb. 26, 2022 -- Dupixent 300 mg weekly is the only biologic medicine to…
Today's Top Posts
Wellness Revolution Unleash the Transformative Power of Yoga in the Workplace
Discover how Yoga emerges as a key solution to workplace wellness challenges,…
